Hepatology
RSS
You selected: Hepatology
New Study Confirms Link Between Nonalcoholic Steatohepatitis and Liver Cancer
NASH-Induced Cirrhosis Rivals HCV in Development of Hepatocellular Carcinoma
Alcoholic Cirrhosis Patients had High Prevalence of Complications at Diagnosis
Presence and Type of Complications Predictors of Mortality
Cigarette Smoking, Fructose Consumption Exacerbates Liver Disease
Modifying Risk Factors Essential in Controlling Liver Disease Progression
Hepatitis C Treatment Less Effective in Urban Minority Patients
Urban HCV Patients Adversely Affected by Social Factors In the Health Care Environment
New Therapies Increase Survival Rates in Post-transplant Liver Cancer Patients
Sirolimus-Based Immunosuppression and Radiofrequency Ablation are Promising Treatments for HCC
Targeted Delivery of Losartan Reduces Liver Inflammation and Scaring
Short-Term Therapy with Oral Losartan Not Effective in Reducing Fibrosis
A recent study found that rats with advanced fibrosis that were administered a short-term dose of losartan-M6PHSA had reduced liver inflammation and fibrosis. Those animals treated with oral losartan alone did not experience a similar reduction in disease activity. Results of this study appear in the March issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Ghrelin Mitigates Liver Fibrosis in Animal Models; Regulates Human Fibrosis
Study Suggests Stomach Hormone May Offer Novel Fibrosis Therapy
Spanish researchers determined that rats treated with recombinant ghrelin displayed a reduction in liver fibrosis. Ghrelin, a stomach hormone, reduced the amount of fibrogenic cells by 25% in the treated rodents. Research further showed ghrelin prevented acute liver damage and reduced oxidative stress and inflammation in the animal models. Details of this study are published in the March issue of Hepatology, a journal of the American Association for the Study of Liver Diseases.
Hepatitis B and C Remain Public Health Issue—Up to 5.3 Million Americans Infected
Institute of Medicine Makes Recommendations to Prevent HBV and HCV Infections
Study Confirms Accuracy of Transient Elastography in NAFLD Sonic Detection of Liver Stiffness Emerges as a Useful Screening and Prognostic Test
Researchers from France and Hong Kong determined that transient elastography (TE), a noninvasive, ultrasonic imaging modality, can be accurately performed in the majority of patients with nonalcoholic fatty liver disease (NAFLD) to exclude advanced fibrosis. Full findings of this study, funded by the Chinese University of Hong Kong, appear in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Non-alcoholic Fatty Liver Disease Associated with High Mortality Rates
Researchers from the Karolinska Institute determined that patients with nonalcoholic fatty liver disease (NAFLD) have a higher overall mortality rate compared with the general population. Details of this study are available in the February issue of Hepatology, a journal published by Wiley-Blackwell on behalf of the American Association for the Study of Liver Diseases.
Caffeine Consumption Associated with Less Severe Liver Fibrosis
Study Finds Caffeine in Sources other than Coffee Does Not Have Similar Effect
Liver Stiffness Measurements Identify Patients with Rapid or Slow Fibrosis
Life-Saving Therapeutic Interventions Possible with Early Detection of Hepatitis C Recurrence
Metobolomics Uncovers Key Indicators of Nonalcoholic Fatty Liver Disease
Impaired Oxidation in Liver Associated with Progression to NASH
Alarming Trend—Antiviral Therapy to Treat Hepatitis C is Declining in the U.S.
Research Suggests Lack of Diagnosis is Primary Barrier to Treatment
Scientists Identify Specific Markers that Trigger Aggressiveness of Liver Cancer
Patients with Positive Epithelial-Mesenchymal Transition Markers Have Lowest Survival Rate
Drinking Coffee Slows Progression of Liver Disease in Chronic Hepatitis C Sufferers
Patients with chronic hepatitis C and advanced liver disease who drink three or more cups of coffee per day have a 53% lower risk of liver disease progression than non-coffee drinkers.
Patients with Cirrhosis and Impaired Cognitive Abilities Have More Motor Vehicle Accidents
Up to 80% of Cirrhotic Patients Develop Difficulties with Cognitive Function
Regular Aerobic Exercise Reduces Health Concerns Associated with Fatty Liver
Benefits Are Not Dependent On Weight Loss - Research News from Hepatology
Study Finds Adverse Effects in Treatment for Primary Sclerosing Cholangitis: High-Dose Ursodeoxycholic Acid Associated with Worsened Disease State for Patients with PSC
Research News from Hepatology